Caspases: Key mediators of apoptosis

Chemistry and Biology

Volumn 5, Issue 5, 1998, Pages

  Thornberry, Nancy A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032078217     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90615-9     Document Type: Short Survey

References (32)

1. Ellis, R.E., Yuan, J. & Horvitz, H.R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698.
2. Thompson, C.B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
3. Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M. & Horvitz, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75, 641-652.
4. Black, R.A., Kronheim, S.R. & Sleath, P.R. (1989). Activation of interleukin-1β by a co-induced protease. FEBS Lett. 247, 386-390.
5. Kostura, M.J., et al., & Schmidt, J.A. (1989). Identification of a monocyte specific pre-interleukin 1β convertase activity. Proc. Natl Acad. Sci. USA 86, 5227-5231.
6. Thornberry, N.A., et al., & Tocci, M.J. (1992). A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356, 768-774.
7. Cerretti, D.P., et al., & Black, R.A. (1992). Molecular cloning of the interleukin-1β converting enzyme. Science 256, 97-100.
8. Kuida, K., et al., & Flavell, R.A. (1995). Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000-2003.
9. Li, P., et al., & Seshadri, T. (1995). Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 80, 401-411.
10. Kuida, K., et al., & Flavell, R.A. (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384, 368-372.
11. Nicholson, D.W. & Thornberry, NA (1997). Caspases: killer proteases. Trends. Biol. Sci. 22, 299-306.
12. Nicholson, D.W., et al., & Miller, D.K. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
13. Wilson, K.P., et al., & Livingston, D.J. (1994). Structure and mechanism of interleukin-1β converting enzyme. Nature 370, 270-275.
14. 2 homodimer. Cell 78, 343-352.
15. Rotonda, J., et al., & Becker, J.W. (1996). The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat. Struct. Biol. 3, 619-625.
16. Howard, A.D., et al., & Tocci, M.J. (1991). IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31 kDa IL-1α. J. Immunol. 147, 2964-2969.
17. Sleath, P.R., Hendrickson, R.C., Kronheim, S.R., March, C.J. & Black, R.A. (1990). Substrate specificity of the protease that processes human interleukin-1β. J. Biol. Chem. 265, 14526-14528.
18. Rano, T.A., et al., & Thornberry, N.A. (1997). A combinatorial approach for determining protease specificities: application to interleukin-1β converting enzyme (ICE). Chem. Biol. 4, 149-155.
19. Thornberry, N.A., et al., & Nicholson, D.W. (1997). A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272, 17907-17911.
20. Rich, D.H. (1986). In Proteinase Inhibitors (Barrett, A.J. & Salvesen, G., eds), pp. 153-178, Elsevier, Amsterdam.
21. Shaw, E. (1990). Cysteinyl proteinases and their selective inactivation. Advances in Enzymology 63, 271-347.
22. Mjalli, A.M.M., Chapman, K.T., MacCoss, M. & Thornberry, N.A. (1993). Phenylalkyl ketones as potent reversible inhibitors of interleukin-1β converting enzyme, Bioorg. Med. Chem. Lett. 3, 2689-2692.
23. Smith, R.A., et al., & Krantz, A. (1988). New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategy. J. Am. Chem. Soc. 110, 4429-4431.
24. Krantz, A., Copp, L.J., Coles, P.J., Smith, R.A. & Heard, S.B. (1991) Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: The departing group as a variable structural element in the design of inactivators of cysteine proteinases. Biochemistry 30, 4678-4687.
25. Thornberry, N.A., Peterson, E.P., Zhao, J.J., Howard, A.D., Griffin, P.R. & Chapman, K.T. (1994). Inactivation of interleukin-1β converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry 33, 3934-3940.
26. Dolle, R.E., et al., & Ator, MA (1996). First examples of peptidomimetic inhibitors of interleukin-1β converting enzyme. J. Med. Chem. 39, 2438-2440.
27. Dolle, R.E., et al., & Ator, M.A. (1997). Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1β-converting enzyme inhibitor. J. Med. Chem. 40, 1941-1946.
28. Ray, C.A., et al., & Pickup, D.J. (1992). Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69, 597-604.
29. Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V.M. & Salvesen, G.S. (1997). Target protease specificity of the viral serpin CrmA. J. Biol. Chem. 272, 7797-7800.
30. Bump, N.J., et al. & Wong, W.W. (1995). Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269, 1885-1888.
31. Deveraux, Q.L., Takahashi, R., Salvesen, G.S. & Reed, J.C. (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388, 300-304.
32. Roy, M., et al., & MacKenzie, A. (1995). The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80, 167-178.